|
US3357956A
(en)
|
1965-03-30 |
1967-12-12 |
Du Pont |
Polymeric 1, 3, 4-thiadiazoles and the process for their preparation
|
|
CH482394A
(de)
|
1966-09-14 |
1969-12-15 |
Shell Int Research |
Herbizides Mittel
|
|
FR2097737A5
(en)
*
|
1970-07-14 |
1972-03-03 |
Berlin Chemie Veb |
Virustatic 4-substd 1-acylthiosemicarbazides -from carboxylic acid - hydrazide and isothiocyanates or from carboxylic acid chloride and 4-
|
|
DE2037257A1
(en)
|
1970-07-28 |
1972-02-03 |
Farbwerke Hoechst AG, vorm. Meister Lucius & Brüning, 6000 Frankfurt |
Poly-(5-amino-1,3,4-thiadiazol-2-yl) derivs prepn - intermediates for drug and polymer prodn
|
|
GB1336575A
(en)
|
1970-12-22 |
1973-11-07 |
Ilford Ltd |
Seleno-semicarbazides
|
|
GB1272920A
(en)
|
1971-03-15 |
1972-05-03 |
Berlin Chemie Veb |
New thiosemicarbazides
|
|
DE2348808C3
(de)
*
|
1973-09-28 |
1980-10-09 |
Hoechst Ag, 6000 Frankfurt |
Formmasse auf Poly(oxymethylen)-Basis
|
|
US4012360A
(en)
|
1973-12-03 |
1977-03-15 |
Ciba-Geigy Corporation |
Bis-salicyloyl-dicarboxylic acid dihydrazides as stabilizers for polyolefines
|
|
JPS5519847Y2
(enExample)
|
1973-12-20 |
1980-05-12 |
|
|
|
JPS583499B2
(ja)
|
1975-07-28 |
1983-01-21 |
旭化成株式会社 |
アンテイカサレタ ポリウレタンソセイブツ
|
|
US4258151A
(en)
|
1979-01-26 |
1981-03-24 |
Sloan-Kettering Institute For Cancer Research |
Pentapeptide modified resin
|
|
US4515954A
(en)
|
1981-08-24 |
1985-05-07 |
American Cyanamid Company |
Metal chelates of anthracene-9,10-bis-carbonylhydrazones
|
|
US4490080A
(en)
|
1983-02-18 |
1984-12-25 |
Precision Industries, Inc. |
Hole cutting tool
|
|
JPS59201047A
(ja)
*
|
1983-04-30 |
1984-11-14 |
Konishiroku Photo Ind Co Ltd |
ハロゲン化銀写真要素
|
|
ATE72431T1
(de)
|
1985-08-31 |
1992-02-15 |
Fisons Plc |
5-gliedrige heterocyclische angiotensinumwandlungsenzym-inhibitoren.
|
|
US4822777A
(en)
|
1987-02-27 |
1989-04-18 |
Liposome Technology, Inc. |
Amphotericin B/cholesterol sulfate composition
|
|
JP2767241B2
(ja)
|
1987-04-15 |
1998-06-18 |
ロ−ム アンド ハ−ス コンパニ− |
殺虫性のｎ−（場合により置換された）−ｎ′−置換−ｎ，ｎ′−ジ置換ヒドラジン
|
|
US4826866A
(en)
|
1987-11-02 |
1989-05-02 |
A. H. Robins Company, Incorporated |
3-amino-5-methyl-1H-pyrazole-4-carboxylic acids and esters thereof as anticonvulsants, muscle relaxants and anxiolytics
|
|
CA1340899C
(en)
|
1988-03-09 |
2000-02-15 |
Andre Bardy |
Procede de preparation de complexes nitruro 99m tc, 186 re ou 188 re utilisables comme produits radiopharmaceutiques
|
|
US6013836A
(en)
|
1992-02-28 |
2000-01-11 |
Rohm And Haas Company |
Insecticidal N'-substituted-N,N'-disubstitutedhydrazines
|
|
FR2697752B1
(fr)
|
1992-11-10 |
1995-04-14 |
Rhone Poulenc Rorer Sa |
Compositions antitumorales contenant des dérivés du taxane.
|
|
US5814658A
(en)
|
1992-12-09 |
1998-09-29 |
Rhone-Poulenc Rorer S.A. |
Taxoids, their preparation and pharmaceutical compositions containing them
|
|
US6749868B1
(en)
|
1993-02-22 |
2004-06-15 |
American Bioscience, Inc. |
Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
|
|
US5439686A
(en)
|
1993-02-22 |
1995-08-08 |
Vivorx Pharmaceuticals, Inc. |
Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor
|
|
US6753006B1
(en)
|
1993-02-22 |
2004-06-22 |
American Bioscience, Inc. |
Paclitaxel-containing formulations
|
|
US6096331A
(en)
|
1993-02-22 |
2000-08-01 |
Vivorx Pharmaceuticals, Inc. |
Methods and compositions useful for administration of chemotherapeutic agents
|
|
US5916596A
(en)
|
1993-02-22 |
1999-06-29 |
Vivorx Pharmaceuticals, Inc. |
Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
|
|
CA2155947C
(en)
|
1993-02-22 |
2007-08-21 |
Mark W. Grinstaff |
Methods for in vivo delivery of biologics and compositions useful therefor
|
|
US6537579B1
(en)
|
1993-02-22 |
2003-03-25 |
American Bioscience, Inc. |
Compositions and methods for administration of pharmacologically active compounds
|
|
US5665382A
(en)
|
1993-02-22 |
1997-09-09 |
Vivorx Pharmaceuticals, Inc. |
Methods for the preparation of pharmaceutically active agents for in vivo delivery
|
|
US5840746A
(en)
|
1993-06-24 |
1998-11-24 |
Merck Frosst Canada, Inc. |
Use of inhibitors of cyclooxygenase in the treatment of neurodegenerative diseases
|
|
US5523325A
(en)
|
1993-09-09 |
1996-06-04 |
Jacobson; Richard M. |
Amidrazones and their use as pesticides
|
|
BR9507914A
(pt)
|
1994-06-03 |
1997-09-23 |
Basf Ag |
Carbamoil-carbo hidrazida processo para preparar carbamoil-carbo-hidrazida composição adequada e processo para controlar fungos nocivos uso da carbamoil-carbo-hidrazida e amino-ácido-hidrazida
|
|
CA2166676C
(en)
|
1995-01-09 |
2007-05-01 |
Yasuhisa Fujibayashi |
Diagnostic agent for hypoxia or mitochondrial dysfunction comprising radioactive copper complex of dithiosemicarbazone derivative or diamine diol schiff base derivative
|
|
DE69604298T2
(de)
|
1995-09-22 |
2000-05-18 |
Bioimage A/S, Soeborg |
Varianten des grünen fluoreszenzproteins, gfp
|
|
US5739686A
(en)
|
1996-04-30 |
1998-04-14 |
Naughton; Michael J. |
Electrically insulating cantilever magnetometer with mutually isolated and integrated thermometry, background elimination and null detection
|
|
JPH1031282A
(ja)
*
|
1996-05-17 |
1998-02-03 |
Fuji Photo Film Co Ltd |
熱現像感光材料
|
|
US5753200A
(en)
|
1996-10-07 |
1998-05-19 |
Solvay Minerals, Inc. |
Sodium metabisulfite process
|
|
US6235787B1
(en)
|
1997-06-30 |
2001-05-22 |
Hoffmann-La Roche Inc. |
Hydrazine derivatives
|
|
GB9727524D0
(en)
|
1997-12-31 |
1998-02-25 |
Pharmacia & Upjohn Spa |
Synergistic antitumor composition containing a biologically active ureido compound
|
|
US20030195268A1
(en)
|
1998-05-20 |
2003-10-16 |
Freitag James W. |
Novel foaming compositions and methods for making and using the composition
|
|
TW479053B
(en)
|
1998-10-19 |
2002-03-11 |
Agro Kanesho Co Ltd |
Hydrazineoxoacetamide derivatives and pesticides
|
|
ES2161594B1
(es)
|
1998-12-17 |
2003-04-01 |
Servier Lab |
Nuevos derivados de la hidrazida, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
|
|
US6136846A
(en)
|
1999-10-25 |
2000-10-24 |
Supergen, Inc. |
Formulation for paclitaxel
|
|
US6670330B1
(en)
|
2000-05-01 |
2003-12-30 |
Theodore J. Lampidis |
Cancer chemotherapy with 2-deoxy-D-glucose
|
|
US6322303B1
(en)
|
2000-05-12 |
2001-11-27 |
David M. John |
Dunnage bag and method of making same
|
|
EP1164126A1
(de)
|
2000-06-16 |
2001-12-19 |
Basf Aktiengesellschaft |
Salicylsäurehydrazid-Derivate, Verfahren und Zwischenprodukte zu ihrer Herstellung, sie enthaltende Mittel und ihre Verwendung zur Bekämpfung von Schadpilzen
|
|
US6365745B1
(en)
|
2000-07-14 |
2002-04-02 |
Sumika Fine Chemicals Co., Ltd. |
Method for producing hydrazine derivative
|
|
EP1365796A2
(en)
|
2000-09-01 |
2003-12-03 |
Van Andel Institute |
Inhibition of mitogen-activated protein kinase (mapk) pathway: a selective therapeutic strategy against melanoma
|
|
MXPA03006666A
(es)
*
|
2001-01-25 |
2004-05-31 |
Guilford Pharm Inc |
Compuestos de union de ciclofilina carbociclicos trisubstituidos y su uso.
|
|
US20020198160A1
(en)
|
2001-05-01 |
2002-12-26 |
Everitt Elizabeth A. |
Compositions and methods for enhancing the bioavailability of pharmaceutical agents
|
|
US20040235813A1
(en)
|
2001-05-03 |
2004-11-25 |
Erich Wanker |
Compounds that inhibit hsp90 and stimulate hsp70 and hsp40, useful in the prevention or treatment of diseases associated with protein aggregation and amyloid formation
|
|
US6602907B1
(en)
|
2001-06-08 |
2003-08-05 |
University Of Central Florida |
Treatment of breast cancer
|
|
DE60213998T2
(de)
|
2001-06-20 |
2007-02-01 |
KURARAY CO., LTD, Kurashiki |
Verfahren zur herstellung von 2 oxocarbonsäureestern
|
|
US6924312B2
(en)
*
|
2001-07-10 |
2005-08-02 |
Synta Pharmaceuticals Corp. |
Taxol enhancer compounds
|
|
TWI297335B
(en)
|
2001-07-10 |
2008-06-01 |
Synta Pharmaceuticals Corp |
Taxol enhancer compounds
|
|
TWI252847B
(en)
|
2001-07-10 |
2006-04-11 |
Synta Pharmaceuticals Corp |
Synthesis of taxol enhancers
|
|
TWI332943B
(en)
|
2001-07-10 |
2010-11-11 |
Synta Pharmaceuticals Corp |
Taxol enhancer compounds
|
|
MXPA02010231A
(es)
|
2001-11-27 |
2004-12-13 |
Warner Lambert Co |
Inhibidores aminotransferasa dependientes de aminoacidos de cadena ramificada y su uso en el tratamiento de las enfermedades neurodegenerativas.
|
|
AU2002361345B8
(en)
|
2001-11-28 |
2008-06-26 |
Ipsen Pharma S.A.S. |
5-sulphanyl-4H-1,2,4-triazole derivatives and their use as medicine
|
|
TW200408407A
(en)
|
2001-11-30 |
2004-06-01 |
Dana Farber Cancer Inst Inc |
Methods and compositions for modulating the immune system and uses thereof
|
|
US20050095592A1
(en)
|
2002-02-13 |
2005-05-05 |
Jazaeri Amir A. |
Identification of ovarian cancer tumor markers and therapeutic targets
|
|
BR122019027966B8
(pt)
|
2002-05-02 |
2021-07-27 |
Wyeth Corp |
conjugado monomérico de derivado de caliqueamicina/anti-corpo anti-cd22 e uso dos mesmos
|
|
WO2004024727A2
(en)
|
2002-09-13 |
2004-03-25 |
Synta Pharmaceuticals Corp. |
Synthesis of indolizines
|
|
AU2006228035B2
(en)
|
2003-01-15 |
2010-02-18 |
Synta Pharmaceuticals Corp. |
Bis (thio-hydrazide amide) compounds for treating multi-drug resistant cancer
|
|
TWI330079B
(en)
|
2003-01-15 |
2010-09-11 |
Synta Pharmaceuticals Corp |
Treatment for cancers
|
|
KR101166749B1
(ko)
|
2003-02-11 |
2012-07-27 |
베르날리스(캠브리지)리미티드 |
열쇼크 단백질 저해제로서의 이소옥사졸 화합물
|
|
KR100575251B1
(ko)
|
2003-03-03 |
2006-05-02 |
재단법인서울대학교산학협력재단 |
ｐ38／ＪＴＶ－1을 유효성분으로 하는 암 치료용 약학적조성물 및 암 치료용 약학적 조성물의 스크리닝 방법
|
|
EP1493445A1
(en)
|
2003-07-04 |
2005-01-05 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Inhibition of stress-induced ligand-dependent EGFR activation
|
|
TWI339206B
(en)
|
2003-09-04 |
2011-03-21 |
Vertex Pharma |
Compositions useful as inhibitors of protein kinases
|
|
JPWO2005035512A1
(ja)
|
2003-10-10 |
2006-12-21 |
協和醗酵工業株式会社 |
チアジアゾリン誘導体
|
|
KR100544347B1
(ko)
|
2003-12-11 |
2006-01-23 |
한국생명공학연구원 |
디아릴이소옥사졸계 화합물을 유효성분으로 함유하는 암 예방 및 치료용 약학적 조성물
|
|
JP2007530589A
(ja)
|
2004-03-26 |
2007-11-01 |
アンフォラ ディスカバリー コーポレーション |
特定のトリアゾールを基礎とする化合物、組成物、およびそれらの使用
|
|
CA2563316A1
(en)
*
|
2004-04-06 |
2005-10-20 |
Semafore Pharmaceuticals, Inc. |
Pten inhibitors
|
|
US7385084B2
(en)
|
2004-06-23 |
2008-06-10 |
Synta Pharmaceutical Corp. |
Bis(thio-hydrazide amide) salts for treatment of cancers
|
|
EP1773756A2
(en)
|
2004-07-09 |
2007-04-18 |
Elan Pharmaceuticals, Inc. |
Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors
|
|
WO2006033913A2
(en)
|
2004-09-16 |
2006-03-30 |
Synta Pharmaceuticals Corp. |
Bis (thio-hydrazide amides) for treament of hyperplasia
|
|
US20060167106A1
(en)
*
|
2004-11-19 |
2006-07-27 |
Mei Zhang |
Compounds acting at the centrosome
|
|
AU2005306471B2
(en)
*
|
2004-11-19 |
2009-12-17 |
Synta Pharmaceuticals Corp. |
Bis(thio-hydrazide amides) for increasing Hsp70 expression
|
|
NZ560712A
(en)
|
2005-02-17 |
2010-12-24 |
Synta Pharmaceuticals Corp |
(3,4,5-trisubstituted-phenyl)isoxazole combretastin derivatives for the treatment of disorders
|
|
EP1877048A1
(en)
|
2005-04-15 |
2008-01-16 |
Synta Pharmaceuticals Corporation |
Combination cancer therapy with bis(thiohydrazide) amide compounds
|
|
WO2006113493A2
(en)
|
2005-04-15 |
2006-10-26 |
Synta Pharmaceuticals Corp. |
Methods of determining cancer prognosis via natural killer cell activity
|
|
WO2006113572A1
(en)
|
2005-04-15 |
2006-10-26 |
Synta Pharmaceuticals Corp. |
Methods of increasing natural killer cell activity for therapy
|
|
MX2007014314A
(es)
|
2005-05-16 |
2008-02-11 |
Synta Pharmaceuticals Corp |
Sintesis de sales de bis(tio-hidrazida amida).
|
|
MX2008002152A
(es)
|
2005-08-16 |
2008-04-19 |
Synta Pharmaceuticals Corp |
Formulacion de bis(tio-hidrazida amida.
|
|
AR057976A1
(es)
*
|
2005-08-29 |
2008-01-09 |
Boehringer Ingelheim Int |
Biarilos sustituidos y su uso como medicamentos.
|
|
SI22254A
(sl)
|
2006-04-13 |
2007-10-31 |
Univerza V Ljubljani Fakulteta Za Farmacijo |
NOVI ARILSULFONOHIDRAZIDNI INHIBITORJI ENCIMOV MurC IN MurD
|
|
CA2653222A1
(en)
|
2006-05-25 |
2007-12-06 |
Synta Pharmaceuticals Corp. |
Triazole compounds that modulate hsp90 activity
|
|
AU2007288336B2
(en)
|
2006-08-21 |
2011-04-21 |
Synta Pharmaceuticals Corp. |
Bis(thiohydrazide amides) for use in preventing or delaying the recurrence of melanoma
|
|
US20100068174A1
(en)
|
2006-08-21 |
2010-03-18 |
Synta Pharmaceuticals Corp. |
Combination with bis (thiohydrazide amides) for treating cancer
|
|
CA2661440A1
(en)
|
2006-08-21 |
2008-02-28 |
Synta Pharmaceuticals Corp. |
Compounds for treating proliferative disorders
|
|
WO2008024298A1
(en)
|
2006-08-21 |
2008-02-28 |
Synta Pharmaceuticals Corp. |
Bis(thiohydrazide amides) for inhibiting angiogenesis
|
|
AU2007288340A1
(en)
|
2006-08-21 |
2008-02-28 |
Synta Pharmaceuticals Corp. |
Bis (thiohydrazide amides) for treating melanoma
|
|
CA2660531A1
(en)
|
2006-08-21 |
2008-02-28 |
Synta Pharmaceutical Corp. |
Compounds for treatment of proliferative disorders
|
|
KR20090045354A
(ko)
|
2006-08-21 |
2009-05-07 |
신타 파마슈티칼스 코프. |
증식성 장애를 치료하기 위한 화합물
|
|
WO2008027445A2
(en)
|
2006-08-31 |
2008-03-06 |
Synta Pharmaceuticals Corp. |
Combination with bis(thiohydrazide amides) for treating cancer
|
|
EP2061430A2
(en)
|
2006-09-11 |
2009-05-27 |
Synta Pharmaceuticals Corporation |
Bis (thiohydrazide amides) formulation
|
|
JP2010503674A
(ja)
|
2006-09-14 |
2010-02-04 |
シンタ ファーマシューティカルズ コーポレーション |
血管形成治療用化合物
|
|
WO2008033494A2
(en)
|
2006-09-15 |
2008-03-20 |
Synta Pharmaceuticals Corp. |
Purification of bis(thiohydrazide amides)
|
|
EP2096111A1
(en)
*
|
2006-11-20 |
2009-09-02 |
Japan Tobacco Inc. |
Pyrazoles and use thereof as drugs
|
|
US20090093538A1
(en)
|
2007-01-03 |
2009-04-09 |
Synta Pharmaceuticals Corp |
Method for treating cancer
|
|
US8093425B2
(en)
|
2007-04-30 |
2012-01-10 |
Synta Pharmaceuticals Corp. |
Compounds for treating proliferative disorders
|
|
US8729111B2
(en)
|
2007-08-07 |
2014-05-20 |
Synta Pharmaceuticals Corp. |
Compounds for treating proliferative disorders
|
|
US8618170B2
(en)
|
2007-11-09 |
2013-12-31 |
Synta Pharmaceuticals Corp. |
Oral formulations of bis(thiohydrazide amides)
|
|
EP2225201A2
(en)
|
2007-11-28 |
2010-09-08 |
Synta Pharmaceuticals Corp. |
Polymorphs of n-malonyl-bis(n'-methyl-n'-thiobenzoylhydrazide)
|
|
TW200940050A
(en)
|
2007-11-28 |
2009-10-01 |
Synta Pharmaceuticals Corp |
Polymorphs of N-malonyl-bis(N'-methyl-N'-thiobenzoylhydrazide)
|
|
JP2011506467A
(ja)
|
2007-12-14 |
2011-03-03 |
サイクローン・ファーマシューティカルズ・インコーポレイテッド |
抗悪性腫瘍性熱ショックアポトーシス活性化因子（ｈｓａａ）と組み合わせられたアルファチモシンペプチドによる黒色腫の処置の方法
|
|
WO2009105257A1
(en)
|
2008-02-21 |
2009-08-27 |
Synta Pharmaceuticals Corp. |
Compounds for treating proliferative disorders
|
|
US8633323B2
(en)
|
2008-03-31 |
2014-01-21 |
Synta Pharmaceuticals Corp. |
Process for preparing bis(thiohydrazide amides)
|
|
US20120003156A1
(en)
|
2008-07-01 |
2012-01-05 |
The Johns Hopkins University |
Methods for treating neoplasia by inhibiting lactate dehydrogenase and/or nicotinamide phosphoribosyltransferase
|
|
BRPI0919720A2
(pt)
|
2008-10-22 |
2015-12-08 |
Synta Pharmaceuticals Corp |
complexos de metal de transição de compostos bis-[tio hidrazida amida
|
|
CN102256949B
(zh)
|
2008-10-22 |
2014-09-24 |
辛塔医药品有限公司 |
双[硫代酰肼酰胺]化合物的过渡金属络合物
|
|
US8680100B2
(en)
|
2008-12-01 |
2014-03-25 |
Synta Pharmaceuticals Corp. |
Sulfonylhydrazide compounds for treating proliferative disorders
|
|
WO2011069159A2
(en)
|
2009-12-04 |
2011-06-09 |
Synta Pharmaceuticals Corp. |
Bis[thiohydrazide amide] compounds for treating leukemia
|
|
WO2011133673A1
(en)
|
2010-04-20 |
2011-10-27 |
Synta Pharmaceuticals Corp. |
Use of bis [thiohydrazide amide] compounds such as elesclomol for treating cancers
|
|
TWI403871B
(zh)
|
2010-10-25 |
2013-08-01 |
Ind Tech Res Inst |
伺服馬達驅動之回授切換裝置及方法
|
|
EP2776021A1
(en)
|
2011-11-10 |
2014-09-17 |
Synta Pharmaceuticals Corp. |
Administration of a bis(thiohydrazide amide) compound for treating cancers
|
|
US20130149392A1
(en)
|
2011-12-12 |
2013-06-13 |
Synta Pharmaceuticals Corp. |
Method of treating non-small cell lung cancer with bis-(thiohydrazide)amide compounds
|